Results 111 to 120 of about 34,447 (237)
Nathaniel Tracer,1 Jaime E Dickerson Jr,2,3 Nathan M Radcliffe4 1NYU School of Medicine, New York, NY, USA; 2Sight Sciences, Inc, Menlo Park, CA, USA; 3North Texas Eye Research Institute, UNTHSC, Fort Worth, TX, USA; 4Mt Sinai School of Medicine, New ...
Tracer N, Dickerson JE Jr, Radcliffe NM
doaj
The making of multispecific immunoglobulins - a clinical perspective. [PDF]
Brinkmann U, Kontermann RE.
europepmc +1 more source
Clinical Debates in Minimally Invasive Glaucoma Surgeries (MIGSs). [PDF]
Chihara E.
europepmc +1 more source
Progress in Glaucoma Management in the Era of Value-Based Healthcare. [PDF]
Ehongo A.
europepmc +1 more source
Preoperative Diagnosis of Symptomatic Adenomyosis: Limitations and Clinical Insights. [PDF]
Pereira M +5 more
europepmc +1 more source
Erenumab was approved in Europe for migraine prevention in patients with ≥ 4 monthly migraine days (MMDs). In Spain, Novartis started a personalized managed access program, which allowed free access to erenumab before official reimbursement. The Spanish Neurological Society started a prospective registry to evaluate real-world effectiveness and ...
Belvís, Roberto|| +25 more
openaire +1 more source
MIGS: A Modular Edge Gateway with Instance-Based Isolation for Heterogeneous Industrial IoT Interoperability. [PDF]
Ai Y, Zhu Y, Jiang Y, Deng Y.
europepmc +1 more source
An Examination of Demographic Involvement in Minimally Invasive Glaucoma Surgery and Cataract Surgery Clinical Trials: A Systematic Review. [PDF]
Appelbaum J, Virk A, Patel D, Allison K.
europepmc +1 more source
Jaime E Dickerson Jr,1,2 Alison E Harvey,1 Reay H Brown1,3 1Sight Sciences, Inc., Menlo Park, CA, USA; 2North Texas Eye Research Institute, University of North Texas Health Science Center, Fort Worth, TX, USA; 3Atlanta Ophthalmology Associates, Atlanta ...
Dickerson JE Jr, Harvey AE, Brown RH
doaj

